Hi all,

Consider 20 samples at baseline later exposed to treatment. 10 develop a
disease and 10 do not develop a disease. Here we want to make a
longitudinal assessment of gene expression in the diseased vs disease-free.
All done on Affy microarrays.

Are there any obvious reasons why one would consider limma over GEE for
testing for conditional or disease related outcomes?

Cheers,

Michael

	[[alternative HTML version deleted]]

